NL-OMON49268招募中2 期
Resveratrol as potential aortic growth inhibitor in patients with Marfan Syndrome - RESVcue Marfan
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Marfan patients with a known FBN1 mutation
- •- Between 18-50 years of age
- •- Native aortic root (n<=50) or aortic root replacement (n<=50)
- •- At least 2 echocardiography measurements and 1 MRI scan of the aorta prior to
- •- Sinus rythm
排除标准
- •- More than one vascular prosthesis
- •- Aortic root diameter > 45 mm
- •- Aortic surgery likely within 6 months of inclusion
- •- Aortic surgery in the last 6 months prior to inclusion
- •- Aortic dissection
- •- Contraindications for MR imaging
- •- Mental retardation
研究者
相似试验
招募中
不适用
Influence of resveratrol (grappe seed extract) on heart beats at rest and during exercise in adults with hypertension.C14.907.489HypertensionRBR-2xj368Instituto Federal de Educação, Ciência e Tecnologia do Sudeste de Minas Gerais
Unknown
3 期
Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to BedsideDilated CardiomyopathyNCT01914081St. Boniface Hospital40
招募中
3 期
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
尚未招募
2 期
Effects of taking an oral anti-oxidant supplement on blood clot formation before and after liver surgeryiver cancerACTRN12617001623381Kwok Ming Ho20
已完成
1 期
Effects of Resveratrol Supplements on Vascular Health in Postmenopausal WomenCardiovascular DiseaseNCT01564381University of California, Davis64